246. Methylmalonic acidemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 28 / Drugs : 25 - (DrugBank : 9) / Drug target genes : 18 - Drug target pathways : 26
Methylmalonic acidemia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 246 | Methylmalonic acidemia | - |
| 236 | Pseudohypoparathyroidism | 15.812 |
| 63 | Idiopathic thrombocytopenic purpura | 15.393 |
| 226 | Interstitial cystitis with Hunners ulcer | 15.294 |
| 299 | Cystic fibrosis | 15.216 |
| 265 | Lipodystrophy | 5.068 |
| 78 | Hypopituitarism | 4.535 |
| 21 | Mitochondrial disease | 4.486 |
| 97 | Ulcerative colitis | 4.002 |
| 96 | Crohn disease | 3.966 |
| 2 | Amyotrophic lateral sclerosis | 3.962 |
| 46 | Malignant rheumatoid arthritis | 3.948 |
| 6 | Parkinson disease | 3.945 |
| 13 | Multiple sclerosis | 3.892 |
| 162 | Pemphigoid | 1.312 |
| 56 | Behcet disease | 1.281 |
| 271 | Ankylosing spondylitis | 1.240 |
| 50 | Dermatomyositis | 1.196 |
| 107 | Juvenile idiopathic arthritis | 1.176 |
| 84 | Sarcoidosis | 1.090 |
| 8 | Huntington disease | 1.087 |
| 245 | Propionic acidemia | 1.000 |